Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry. [PDF]
Open HeartLi OM +12 more
europepmc +1 more source
Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate. [PDF]
Low Urin Tract SymptomsFilzmayer M +8 more
europepmc +1 more source
Structural and biochemical insights into the inhibition of <i>Mycobacterium tuberculosis</i> cyclic dinucleotide phosphodiesterase by a sulfur-modified cyclic dinucleotide analog. [PDF]
RSC Chem BiolHanuman DS +5 more
europepmc +1 more source
Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. [PDF]
Medicine (Baltimore)Alnazari M +6 more
europepmc +1 more source
Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis. [PDF]
Front Med (Lausanne)Mansour GK, Hajjar AW, Sukkarieh HH.
europepmc +1 more source
Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair. [PDF]
Physiol Rep, 2017 Elmadbouh I, Ashraf M.
europepmc +1 more source
Covalent Binding of the Boronic Acid-Based Inhibitor GSK4394835A to Phosphodiesterase 3B, a Drug Target for Cardiovascular Disease. [PDF]
J Med ChemEaton SA, Christianson DW.
europepmc +1 more source
Host GPCR-cAMP signaling balances Gαs and Gαi activity to control intracellular <i>Brucella</i> infection. [PDF]
mBioKang Y-S, Kirby JE.
europepmc +1 more source
Phosphodiesterase signaling in asthma: mechanistic insights and emerging therapeutic strategies. [PDF]
Naunyn Schmiedebergs Arch PharmacolAlnusayri A +6 more
europepmc +1 more source